Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics

Leukemia and Lymphoma

Volumn 49, Issue 4, 2008, Pages 710-718

  Khan, Naveed I ^a   Cisterne, Adam ^a   Devidas, Meenakshi ^b   Shuster, Jonathan ^b   Hunger, Stephen P ^c   Shaw, Peter J ^d   Bradstock, Kenneth F ^e   Bendall, Linda J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

Author keywords

Acute lymphoblastic leukemia; CD44; Chemotherapeutic approaches; Lymphoid leukemia; Neoplasia; Prognosis; Prognostication

Indexed keywords

ANTILEUKEMIC AGENT; CD44V6 ANTIGEN; HERMES ANTIGEN; MESSENGER RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; B CELL LEUKEMIA; B LYMPHOCYTE; CANCER GENETICS; CHILD; CHILDHOOD LEUKEMIA; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANTIGENS, CD44; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 42049104222     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701861660     Document Type: Conference Paper

References (34)

1. Conter, V., Arico, M., Valsecchi, M., Basso, G., Biondi, A. and Madon, E. (2000) Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-995. Leukemia, 14, pp. 2196-2204.
2. Balduzzi, A., Valsecchi, M., Uderzo, C., De Lorenzo, P., Klingebiel, T. and Peters, C. (2005) Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study. Lancet, 366, pp. 635-642.
3. Caglar, K., Varan, A., Akyuz, C., Selek, U., Kutluk, T. and Yalcin, B. (2006) Second neoplasms in pediatric patients treated for cancer: A center's 30-year experience. J Pediatr Hematol Oncol, 28, pp. 374-378.
4. Reddick, W., Shan, Z., Glass, J., Helton, S., Xiong, X. and Wu, S. (2006) Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer, 106, pp. 941-949.
5. Smith, M., Arthur, D., Camitta, B., Carroll, A., Crist, W. and Gaynon, P. (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol, 14, pp. 18-24.
6. Bendall, L. and Gottlieb, D. (1999) CD44 and adhesion of normal and leukaemic CD34+ cells to bone marrow stroma. Leuk Lymphoma, 32, pp. 427-439.
7. Miyake, K., Medina, K. L., Hayashi, S-I, Ono, S., Hamaoka, T. and Kincade, P. W. (1990) Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med, 171, pp. 477-488.
8. Schmits, R., Filmus, J., Gerwin, N., Senaldi, G., Kiefer, F. and Kundig, T. (1997) CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood, 90, pp. 2217-2233.
9. Screaton, G., Bell, M., Jackson, D., Cornelis, F., Gerth, U. and Bell, J. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA, 89, pp. 12160-12164.
10. Ghaffari, S., Dougherty, G., Lansdorp, P., Eaves, A. and Eaves, C. (1995) Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood, 86, pp. 2976-2985.
11. Neu, S., Geiselhart, A., Sproll, M., Hahn, D., Kuci, S. and Niethammer, D. (1997) Expression of CD44 isoforms by highly enriched CD34-positive cells in cord blood, bone marrow and leukaphereses. Bone Marrow Transplant, 20, pp. 593-598.
12. Yamamichi, K., Uehara, Y., Kitamura, N., Nakane, Y. and Hioki, K. (1998) Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer. Int J Cancer, 79, pp. 256-262.
13. Tempfer, C., Lösch, A., Heinzel, H., Häusler, G., Hanzal, E. and Kölbl, H. (1996) Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer, 32, pp. 2023-2025.
14. Mulder, J-W, Kruyt, P., Sewnath, M., Oosting, J., Seldenrijk, C. and Weidema, W. (1994) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344, pp. 1470-1472.
15. Hoshimoto, K., Yamauchi, N., Takazawa, Y., Onda, T., Taketani, Y. and Fukayama, M. (2003) CD44 variant 6 in endometrioid carcinoma of the uterus: Its expression in the adenocarcinoma component is an independent prognostic marker. Pathol Res Pract, 199, pp. 71-77.
16. Concin, N., Hefler, L., van Bavel, J., Mueller-Holzner, E., Zeimet, A. and Daxenbichler, G. (2003) Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases. Gynecol Oncol, 89, pp. 9-15.
17. Miyoshi, T., Kondo, K., Hino, N., Uyama, T. and Monden, Y. (1997) The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Clin Cancer Res, 3, pp. 1289-1297.
18. Legras, S., Günthert, U., Stauder, R., Curt, F., Oliferenko, S. and Kluin-Nelemans, H. (1998) A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood, 91, pp. 3401-3413.
19. Stauder, R., Eisterer, W., Thaler, J. and Gunthert, U. (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood, 85, pp. 2885-2899.
20. Stauder, R., Van Driel, M., Schwarzler, C., Thaler, J., Lokhorst, H. and Kreuser, E. (1996) Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood, 88, pp. 3101-3108.
21. Willman, C., Kang, H., Potter, J., Harvey, R., Atlas, S. and Bedrick, E. A gene expression classifier for improved risk classification and outcome prediction in pediatric acute lymphoblastic leukemia (ALL). Blood, p. 762. Georgia, Atlanta
22. Magyarosy, E., Sebestyen, A. and Timar, J. (2001) Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia. Anticancer Res, 21, pp. 819-823.
23. Bendall, L., Nilsson, S., Khan, N., James, A., Bonnet, C. and Lock, R. (2004) Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burden. Leukemia, 18, pp. 1308-1311.
24. Kortlepel, K., Bendall, L. J. and Gottlieb, D. J. (1993) Human acute myeloid leukemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia, 7, pp. 1174-1179.
25. Vaskova, M., Mejstrikova, E., Kalina, T., Martinkova, P., Omelka, M. and Trka, J. (2005) Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia. Leukemia, 19, pp. 876-878.
26. Yeoh, E., Ross, M., Shurtleff, S., Williams, W., Patel, D. and Mahfouz, R. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1, pp. 133-143.
27. Willenbrock, H., Juncker, A., Schmiegelow, K., Knudsen, S. and Ryder, L. (2004) Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays. Leukemia, 18, pp. 1270-1277.
28. Ross, M., Zhou, X., Song, G., Shurtleff, S., Girtman, K. and Williams, W. (2003) Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood, 102, pp. 2951-2959.
29. Uckun, F., Sensel, M., Sather, H., Gaynon, P., Arthur, D. and Lange, B. (1998) Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: A report from the Children's Cancer Group. J Clin Oncol, 16, pp. 527-535.
30. Takeuchi, M., Tanizawa, A., Fukumoto, Y., Kikawa, Y. and Mayumi, M. (1999) Serum soluble CD44 in pediatric patients with acute leukemia. J Pediatr Hematol Oncol, 21, pp. 384-388.
31. Nasu, H., Hibi, N., Ohyashiki, J., Hara, A., Kubono, K. and Tsukada, Y. (1998) Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes. Int J Oncol, 13, pp. 525-530.
32. Yokota, A., Ishii, G., Sugaya, Y., Nishimura, M., Saito, Y. and Harigaya, K. (1999) Potential use of serum CD44 as an indicator of tumour progression in acute leukemia. Hematol Oncol, 17, pp. 161-168.
33. Tacyildiz, N., Cavdar, A., Yavuz, G., Gozdasoglu, S., Unal, E. and Ertem, U. (2001) Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: Correlation with prognostic criteria and survival. Pediatr Int, 43, pp. 354-360.
34. Mengarelli, A., Zarcone, D., Caruso, R., Tenca, C., Rana, I. and Pinto, R. (2001) Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia. Leuk Lymphoma, 40, pp. 625-630.